Oncology Today with Dr Neil Love cover image

CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson

Oncology Today with Dr Neil Love

00:00

Safety profile of CELMoDs

Paul summarizes adverse events: myelosuppression, neutropenia management, low infection rates, and minimal off-target toxicities.

Play episode from 17:00
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
 Get the app